Axcelis Technologies, Inc (NASDAQ:ACLS) Accelerates Recovery As Margin Expansion Signals Near-Term Upside

Operational leverage and recent corporate catalysts position the company for renewed momentum, while WMDST values the stock as under-valued. Near-term price behavior should reflect a tension between momentum strength and signs of technical overextension.

Recent News

On February 6, 2026 shareholders approved key proposals for the pending all‑stock merger with Veeco Instruments, with closing still subject to regulatory approvals. On March 12, 2026 Axcelis named David Ryzhik Interim Chief Financial Officer, with outgoing CFO James Coogan remaining through April 24 to support transition. On April 20, 2026 the company announced formal Science Based Targets initiative approval of its greenhouse gas reduction targets, and that same week an analyst at B. Riley upgraded the company and raised its price target.

Technical Analysis

Directional indicators show a strong trend environment: ADX reads 44.32, indicating a very strong trend. DI+ sits at 40.41 and shows a peak‑and‑reversal (bearish), while DI‑ at 11.77 displays a dip‑and‑reversal (bearish); together those directional moves imply the existing trend strength accompanies a directional shift toward selling pressure, which raises the risk to immediate upside despite strong trend magnitude.

MACD reads 10.96 with a signal line at 10.04. The MACD has crossed above its signal line, which normally constitutes a bullish cross, yet the MACD trend shows a peak‑and‑reversal, signaling momentum weakening; the combination suggests limited follow‑through above recent levels and vulnerability to a momentum fade.

MRO stands at 34.42 and is positive, indicating the market price sits above the model target and therefore faces a higher probability of a contraction toward fair value; the magnitude of the MRO implies meaningful corrective pressure if momentum rolls over.

RSI registers 65.39 and is rising. The increasing RSI indicates the market moved into stronger buying territory and now approaches overbought thresholds, which supports a near‑term consolidation risk if selling accelerates.

Price sits at $139.99 above shorter‑ and longer‑term averages: 12‑day EMA $132.23 (increasing), 20‑day average $131.41, 50‑day average $101.69 and 200‑day average $88.86. Being above these moving averages shows clear bullish breadth, but the technical overextension (MRO positive, rising RSI, MACD momentum weakening) argues that upside may meet resistance near the consensus price target mean of $144.37 and that support near the super trend lower at $129.47 merits attention as a logical consolidation floor.

 


Fundamental Analysis

Total revenue reached $238.33 million. Revenue shows a QoQ increase of 18.07% but a YoY decline of 8.16%, reflecting recent sequential pickup after softer year‑over‑year comparisons. Gross margin stands at 46.97% with a small YoY expansion of +2.00%, indicating retained product profitability even as sales comparisons lag.

Operating margin equals 15.18% and EBIT margin 17.35%; both show QoQ improvement (operating margin QoQ +29.57%, EBIT margin QoQ +17.84%) but remain below the industry peer mean for operating margin (34.24%) and EBIT margin (34.88%). That gap shows margin recovery while leaving room to converge toward peer averages if cost leverage continues to improve.

Earnings per share came in at $1.49 versus an estimate of $1.12, producing an EPS surprise of $0.37 and an EPS surprise ratio of 33.04%. Reported earnings growth measures show QoQ strength (earnings growth QoQ +226.84%) and a large year‑over‑year increase in reported earnings growth (YoY +589.51%), reflecting a low prior‑year comparison base and the recent operating leverage effect.

Liquidity and balance‑sheet metrics remain pronounced strengths. Cash and short‑term investments total $374.25 million and the current ratio reads 4.77x (above the industry peer mean of 2.15x). Quick ratio 3.11x and cash ratio 1.89x signal strong near‑term coverage, while debt to assets at 3.11% and debt to equity at 4.09% show minimal leverage relative to typical equipment peers.

Cash generation shows signs of strain: operating cash flow was negative at ‑$6.57 million and free cash flow was ‑$8.90 million, producing a negative free cash flow yield (‑0.33%). Working capital dynamics show a cash conversion cycle of 264.72 days, slightly above the industry peer mean of 251.48 days, driven by elevated inventory days outstanding of 238.85 and DSO of 60.52 days.

Valuation multiples display mixed signals. Trailing PE stands at 58.74 with a YoY rise of 20.38%; price‑to‑book sits at 2.60, which lies below the industry peer mean book multiple of 18.26. Forward PE reads 74.05 with forward PEG 3.20. WMDST values the stock as under‑valued, a conclusion that weighs Axcelis’ strong cash position, improving QoQ margins and recent EPS beat against elevated valuation multiples and temporary negative free cash flow.

MOST-RECENT QUARTERLY REPORT
REPORT PERIOD ENDING: 2025-12-31
REPORT DATE: 2026-02-17
NEXT REPORT DATE: 2026-05-19
CASH FLOW  Begin Period Cash Flow 195.1 M
 Operating Cash Flow -6.57 M
 Capital Expenditures -2.33 M
 Change In Working Capital -45.08 M
 Dividends Paid
 Cash Flow Delta -39.05 M
 End Period Cash Flow 156.1 M
 
INCOME STATEMENT REVENUE
 Total Revenue 238.3 M
 Forward Revenue 60.2 M
COSTS
 Cost Of Revenue 126.4 M
 Depreciation 4.5 M
 Depreciation and Amortization 4.5 M
 Research and Development 30.1 M
 Total Operating Expenses 202.2 M
PROFITABILITY
 Gross Profit 111.9 M
 EBITDA 45.8 M
 EBIT 41.4 M
 Operating Income 36.2 M
 Interest Income 4.9 M
 Interest Expense 1.3 M
 Net Interest Income 3.6 M
 Income Before Tax 40.0 M
 Tax Provision 5.7 M
 Tax Rate 14.296 %
 Net Income 34.3 M
 Net Income From Continuing Operations 34.3 M
EARNINGS
 EPS Estimate 1.12
 EPS Actual 1.49
 EPS Difference 0.37
 EPS Surprise 33.036 %
 Forward EPS 1.13
 
BALANCE SHEET ASSETS
 Total Assets 1.4 B
 Intangible Assets
 Net Tangible Assets 1.0 B
 Total Current Assets 943.2 M
 Cash and Short-Term Investments 374.3 M
 Cash 145.5 M
 Net Receivables 168.5 M
 Inventory 329.0 M
 Long-Term Investments 56.6 M
LIABILITIES
 Accounts Payable 42.3 M
 Short-Term Debt
 Total Current Liabilities 197.7 M
 Net Debt
 Total Debt 42.3 M
 Total Liabilities 326.7 M
EQUITY
 Total Equity 1.0 B
 Retained Earnings 503.5 M
VALUATION & PER-SHARE METRICS EQUITY & PER-SHARE METRICS
 Book Value Per-Share 33.68
 Shares Outstanding 30.717 M
 Revenue Per-Share 7.76
VALUATION
 Market Capitalization 2.7 B
 Enterprise Value 2.4 B
 Enterprise Multiple 51.43
Enterprise Multiple QoQ -14.824 %
Enterprise Multiple YoY 73.821 %
Enterprise Multiple IPRWA high: 244.045
median: 114.544
mean: 107.516
ACLS: 51.43
low: -216.655
 EV/R 9.887
CAPITAL STRUCTURE
 Asset To Equity 1.316
 Asset To Liability 4.167
 Debt To Capital 0.039
 Debt To Assets 0.031
Debt To Assets QoQ -1.489 %
Debt To Assets YoY -3.984 %
Debt To Assets IPRWA high: 0.455
median: 0.194
mean: 0.165
ACLS: 0.031
low: 0.003
 Debt To Equity 0.041
Debt To Equity QoQ -2.199 %
Debt To Equity YoY -5.125 %
Debt To Equity IPRWA high: 0.96
mean: 0.266
median: 0.138
ACLS: 0.041
low: -0.408
PRICE-BASED VALUATION
 Price To Book (P/B) 2.598
Price To Book QoQ 3.23 %
Price To Book YoY 8.203 %
Price To Book IPRWA high: 22.471
median: 22.16
mean: 18.264
ACLS: 2.598
low: 1.081
 Price To Earnings (P/E) 58.735
Price To Earnings QoQ -14.197 %
Price To Earnings YoY 20.38 %
Price To Earnings IPRWA high: 422.129
median: 146.908
mean: 139.67
ACLS: 58.735
low: -305.594
 PE/G Ratio 2.538
 Price To Sales (P/S) 11.279
Price To Sales QoQ -6.158 %
Price To Sales YoY 17.075 %
Price To Sales IPRWA high: 71.828
median: 45.349
mean: 41.134
ACLS: 11.279
low: 3.414
FORWARD MULTIPLES
Forward P/E 74.051
Forward PE/G 3.2
Forward P/S 44.659
EFFICIENCY OPERATIONAL
 Operating Leverage 2.72
ASSET & SALES
 Asset Turnover Ratio 0.176
Asset Turnover Ratio QoQ 10.02 %
Asset Turnover Ratio YoY -6.498 %
Asset Turnover Ratio IPRWA high: 0.471
mean: 0.207
median: 0.203
ACLS: 0.176
low: 0.002
 Receivables Turnover 1.508
Receivables Turnover Ratio QoQ 1.111 %
Receivables Turnover Ratio YoY 15.5 %
Receivables Turnover Ratio IPRWA high: 2.887
mean: 1.789
median: 1.515
ACLS: 1.508
low: 0.498
 Inventory Turnover 0.387
Inventory Turnover Ratio QoQ -1.552 %
Inventory Turnover Ratio YoY -18.581 %
Inventory Turnover Ratio IPRWA high: 1.243
mean: 0.516
median: 0.401
ACLS: 0.387
low: 0.174
 Days Sales Outstanding (DSO) 60.516
CASH CYCLE
 Cash Conversion Cycle Days (CCC) 264.715
Cash Conversion Cycle Days QoQ -9.767 %
Cash Conversion Cycle Days YoY 22.066 %
Cash Conversion Cycle Days IPRWA high: 596.302
median: 270.338
ACLS: 264.715
mean: 251.476
low: -64.288
CAPITAL DEPLOYMENT
 Cash Conversion Ratio 0.32
 CapEx To Revenue -0.01
 CapEx To Depreciation -0.523
 
CAPITAL, LIQUIDITY & COVERAGE CAPITAL STRUCTURE
 Total Capital 1.0 B
 Net Invested Capital 1.0 B
 Invested Capital 1.0 B
 Net Tangible Assets 1.0 B
 Net Working Capital 745.5 M
LIQUIDITY
 Cash Ratio 1.893
 Current Ratio 4.772
Current Ratio QoQ -3.504 %
Current Ratio YoY -11.868 %
Current Ratio IPRWA high: 10.619
ACLS: 4.772
median: 2.256
mean: 2.154
low: 1.126
 Quick Ratio 3.107
Quick Ratio QoQ -6.27 %
Quick Ratio YoY -23.36 %
Quick Ratio IPRWA high: 7.834
ACLS: 3.107
median: 1.606
mean: 1.511
low: 0.689
COVERAGE & LEVERAGE
 Debt To EBITDA 0.924
 Cost Of Debt 2.626 %
 Interest Coverage Ratio 30.954
Interest Coverage Ratio QoQ 28.42 %
Interest Coverage Ratio YoY -25.565 %
Interest Coverage Ratio IPRWA high: 99.429
mean: 34.363
median: 32.93
ACLS: 30.954
low: -143.241
 Operating Cash Flow Ratio 0.016
TIMING / LIQUIDITY
 Days Payables Outstanding (DPO) 34.647
DIVIDENDS
 Dividend Coverage Ratio
 Dividend Payout Ratio
 Dividend Rate
 Dividend Yield
PERFORMANCE GROWTH
 Asset Growth Rate 0.696 %
 Revenue Growth 11.572 %
Revenue Growth QoQ 18.07 %
Revenue Growth YoY -816.089 %
Revenue Growth IPRWA high: 40.838 %
mean: 12.779 %
ACLS: 11.572 %
median: 2.725 %
low: -9.892 %
 Earnings Growth 23.14 %
Earnings Growth QoQ 226.836 %
Earnings Growth YoY 589.511 %
Earnings Growth IPRWA high: 266.667 %
ACLS: 23.14 %
mean: 17.364 %
median: 0.794 %
low: -85.714 %
MARGINS
 Gross Margin 46.965 %
Gross Margin QoQ 12.967 %
Gross Margin YoY 2.0 %
Gross Margin IPRWA high: 90.758 %
mean: 52.465 %
median: 52.156 %
ACLS: 46.965 %
low: 9.383 %
 EBIT Margin 17.352 %
EBIT Margin QoQ 17.84 %
EBIT Margin YoY -27.111 %
EBIT Margin IPRWA high: 46.775 %
median: 35.306 %
mean: 34.884 %
ACLS: 17.352 %
low: -49.18 %
 Return On Sales (ROS) 15.177 %
Return On Sales QoQ 29.574 %
Return On Sales YoY -36.247 %
Return On Sales IPRWA high: 69.122 %
median: 35.306 %
mean: 34.24 %
ACLS: 15.177 %
low: -49.18 %
CASH FLOW
 Free Cash Flow (FCF) -8.90 M
 Free Cash Flow Yield -0.331 %
Free Cash Flow Yield QoQ -119.609 %
Free Cash Flow Yield YoY -199.102 %
Free Cash Flow Yield IPRWA high: 2.925 %
mean: 1.469 %
median: 1.229 %
ACLS: -0.331 %
low: -1.389 %
 Free Cash Growth -120.542 %
Free Cash Growth QoQ -913.429 %
Free Cash Growth YoY 49.571 %
Free Cash Growth IPRWA high: 500.136 %
median: -0.341 %
mean: -8.385 %
ACLS: -120.542 %
low: -360.935 %
 Free Cash To Net Income -0.26
 Cash Flow Margin 1.297 %
 Cash Flow To Earnings 0.09
VALUE & RETURNS
 Economic Value Added 0.04
 Return On Assets (ROA) 2.528 %
Return On Assets QoQ 30.108 %
Return On Assets YoY -32.006 %
Return On Assets IPRWA high: 12.607 %
mean: 6.048 %
median: 5.937 %
ACLS: 2.528 %
low: -7.635 %
 Return On Capital Employed (ROCE) 3.554 %
 Return On Equity (ROE) 0.033
Return On Equity QoQ 30.153 %
Return On Equity YoY -32.8 %
Return On Equity IPRWA high: 0.21
median: 0.145
mean: 0.141
ACLS: 0.033
low: -0.241
 DuPont ROE 3.338 %
 Return On Invested Capital (ROIC) 3.425 %
Return On Invested Capital QoQ 28.856 %
Return On Invested Capital YoY -135.306 %
Return On Invested Capital IPRWA high: 11.139 %
median: 10.618 %
mean: 9.022 %
ACLS: 3.425 %
low: -2.702 %

Six-Week Outlook

Expect elevated volatility around integration and regulatory milestones tied to the Veeco merger and the company’s management transition. Technicals present a strong trend backdrop but show signs of momentum topping—watch for consolidation between roughly $129 and the consensus target area near $144. Corporate catalysts (merger progress, sustainability approvals, analyst revisions) could drive episodic spikes; absent sustained momentum, the MRO and rising RSI favor a corrective pullback toward the super trend lower at $129.47 before any renewed trend extension.

About Axcelis Technologies, Inc.

Axcelis Technologies, Inc. (NASDAQ:ACLS) is a distinguished entity in the semiconductor sector, headquartered in Beverly, Massachusetts since 1978. The company is renowned for its expertise in designing and producing ion implantation systems, which are crucial for the fabrication of semiconductor chips. Axcelis serves a global clientele, including regions such as the United States, Japan, Europe, and the Asia Pacific, with a diverse portfolio of high energy, high current, and medium current implanters to accommodate various technological demands. In addition to its state-of-the-art equipment, Axcelis is dedicated to providing a comprehensive suite of aftermarket services. This includes offering refurbished machinery, spare parts, equipment upgrades, and extensive maintenance solutions, ensuring the longevity and efficiency of their products. The company also emphasizes customer education through specialized training programs, empowering clients to maximize the potential of their investments. Axcelis employs a direct sales strategy to connect with semiconductor manufacturers worldwide, prioritizing customer satisfaction and innovation. By continually pushing the boundaries of semiconductor manufacturing technology, Axcelis Technologies solidifies its position as a leader and innovator in the industry.



© 2026 WMDST — The World’s Most Dangerous Swing Trader. All rights reserved.